透皮医疗贴剂市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00024652
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 194
Buy Now

[研究报告]透皮医疗贴剂市场预计将从 2022 年的 82.4721 亿美元增至 2028 年的 107.9974 亿美元。预计 2023 年至 2028 年复合年增长率为 4. 0%。

分析师观点

慢性病患病率的增加和烟草消费的增加推动了透皮医疗贴剂市场的增长。患有慢性病的患者数量不断增加以及研发活动不断增加是推动透皮医疗贴剂市场的关键因素。此外,不断增加的研发活动预计将促进透皮医疗贴剂市场的增长。此外,透皮医疗贴剂市场的主要参与者正在专注于战略举措,通过推出新产品来扩大其地理覆盖范围并增强服务广大客户群的能力。例如,2021年3月,久光制药有限公司宣布批准生产和销售ZICTHORU Tapes 75 mg、经皮NSAID疼痛治疗贴剂,用于治疗“癌痛”。在日本。该产品是采用久光的TDDS(透皮给药系统)技术开发的全身透皮制剂。该产品的功效和安全性已在癌痛患者的临床试验中得到证实。

透皮医疗贴剂市场-市场概况

透皮医疗贴剂,又称贴剂,或药物皮肤贴片,是一种医疗设备,旨在通过皮肤将药物或其他治疗物质输送到血液中。这些贴剂通常是薄的粘性贴剂,直接贴在皮肤上,让药物在特定的时间内逐渐被吸收。透皮贴剂提供了一种方便的药物输送方法。它们可以涂在皮肤上并在特定的时间内使用,通常从几个小时到几天不等,具体取决于药物和所需的治疗效果。

战略视角

推动市场

慢性病患病率上升推动全球透皮医疗贴剂市场

根据美国疾病控制与预防中心 (CDC) 的数据,心脏病、癌症和糖尿病等慢性病占美国年度医疗保健支出的很大一部分(410 万美元)。透皮医疗贴剂用于向患有心脏病、中风、糖尿病、癌症、肥胖症和关节炎等慢性疾病的人提供药物。 。根据世界卫生组织 (WHO) 的数据,2019 年约有 1790 万人死于心血管疾病,占全球死亡人数的 32%。 85%与心血管疾病相关的死亡是由于心脏病发作。据同一消息来源称,2019年,超过四分之三的心血管疾病死亡发生在低收入和中等收入国家,其中1700万人因非传染性疾病过早死亡(70岁以下); 38% 的非传染性疾病死亡原因是心血管疾病。

心脏补片为改善细胞植入提供了绝佳的平台。例如,最近开发的血管化心脏补片显示出治疗缺血性心脏病变的巨大潜力。硝酸甘油透皮贴剂用于预防冠状动脉疾病患者的心绞痛(胸痛)发作。它的作用是放松血管并减少心脏的紧张,从而减少对氧气的需求。然而,这些贴片不能用于治疗已经开始的心绞痛发作。

阿尔茨海默病被正式列为 2019 年美国第六大死因,也是美国第七大死因。 2020 年和 2021 年。根据美国国立卫生研究院 2023 年的统计数据,约 670 万 65 岁及以上的美国人(即每 9 人中就有 1 人或 10.8%)患有阿尔茨海默氏痴呆症。患有阿尔茨海默氏痴呆症的人的比例随着年龄的增长而增加。 65岁至74岁的人中有5%、75岁至84岁的人有13.1%、85岁及以上的人有33.3%患有阿尔茨海默病。根据 2021 年发布的《全球年轻发病痴呆症患病率》报告,在美国,每 10 万名 30 岁至 64 岁的人中,估计有 110 人患有年轻发病痴呆症,即美国总人数约为 20 万。 。因此,65岁以下的人也可能患上阿尔茨海默氏痴呆。

卡巴拉汀贴剂用于治疗与轻度、中度或重度阿尔茨海默氏病或轻度至中度痴呆相关的痴呆(记忆丧失)。与帕金森病有关。卡巴拉汀和多奈哌齐是胆碱酯酶抑制剂,表现出剂量反应关系,药物剂量越高,疗效越好。作为一种亲脂性和亲水性的小分子,卡巴拉汀在化学上适合透皮给药。 。卡巴拉汀贴片所采用的技术使其外观小而薄。因此,卡巴拉汀贴剂可以快速、轻松地获得高剂量疗效。

因此,慢性病患病率的不断上升催化了对医疗贴剂的需求,这增加了透皮医疗贴剂市场中粘合剂中多层药物的需求、储层、蒸气片和基质。母公司细分市场在 2022 年占据最大的市场份额,预计同一细分市场在预测期内复合年增长率最高,为 5.3%。该细分市场的市场地位取决于患者的依从性和便利性。矩阵贴片的设计具有进一步提高患者依从性的功能,例如延长佩戴时间、简化应用或跟踪药物依从性的智能监控功能。该阵列贴片集成了传感器或监控功能,可提供有关患者健康状况的实时信息。

透皮医疗贴剂市场:区域分析

亚太地区是透皮医疗贴剂市场的主导区域。 2022年亚太地区透皮医疗贴剂市场估值为20.2432亿美元,预计到2028年将达到27.4432亿美元;预计在预测期内复合年增长率为 5.2%。亚太地区透皮医疗贴剂市场分为中国、日本、印度和亚太地区其他地区。该区域的增长归因于对癌症和基因突变的研究不断增加、疾病模型的增加以及提供透皮医疗贴剂的市场参与者的进步。医疗保健设施的发展、人口老龄化的增加以及与外国实体合作伙伴关系的增加等因素可能会进一步推动医疗贴剂市场的增长。在预测期内,透皮贴剂< /p>

透皮医疗贴剂市场:主要参与者分析

透皮医疗贴剂市场分析包括久光制药有限公司、Medline Industries L.P.、强生公司等参与者。 Johnson、Novartis AG、Teva Pharmaceutical Industries Ltd、UCB SA、Viatris Inc、Endo Pharmaceuticals Inc、Boehringer Ingelheim International GmbH 和 Corium, LLC。在透皮医疗贴剂市场的参与者中,久光制药有限公司和诺华公司由于提供多样化的产品组合而位居前两名。

透皮医疗贴剂市场:最新发展

透皮贴剂市场的企业大多采用并购等无机和有机策略。下面列出了市场上的一些关键最新进展:

  • 2019 年,Nitto Denko Corporation 宣布推出 Bisono Tape 2 mg,这是与 Toa Eiyo Ltd. 联合开发的含有 β1 阻滞剂的透皮贴剂,由 Toa Eiyo Ltd. 推出Eiyo 和 Astellas Pharma Inc.
  • 2022 年 6 月,Hisamitsu Pharmaceutical Co., Inc. 被批准用于“腰痛、肩胛骨、颈肩周炎”的额外适应症。综合征和腱鞘炎” ZICTHORU 胶带,在日本用于疼痛治疗的透皮 NSAID 贴剂。该产品被批准用于“各种癌症的镇痛”的生产和销售。于 2021 年 3 月获得批准。该批准基于 III 期临床研究的数据,该研究评估了该产品对腰痛、肩胛周围炎、颈臂综合征和腱鞘炎患者的疗效和安全性。随着附加适应症的批准,久光希望该产品将成为治疗腰痛、肩胛周围炎、颈肱肌综合征和腱鞘炎的新选择。
  • 2021年1月,久光Pharmaceutical Co., Inc. 已在美国开始针对治疗骨关节炎膝盖疼痛的透皮镇痛抗炎贴剂的 III 期临床研究。该临床研究将由美国子公司Noven Pharmaceuticals, Inc.进行。研究产品是利用久光的TDDS(透皮给药系统)技术开发的透皮制剂。久光制药预计该研究产品将成为膝骨关节炎的一种新治疗选择,作为透皮制剂的特性之一,通过实现向受影响区域提供更多药物来证明其有效性和安全性。
  • 2022 年 9 月, Corium, Inc 推出了 ADLARITY(多奈哌齐透皮系统),现已在美国通过处方销售,用于治疗轻度、中度或重度阿尔茨海默氏症型痴呆患者。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Who are the major players in the transdermal medical patch market across the globe?

The transdermal medical patch market majorly consists of the players, such as Hisamitsu Pharmaceutical Co Inc, Medline Industries LP, Johnson & Johnson, Novartis AG, Teva Pharmaceutical Industries Ltd, UCB SA, Viatris Inc, Endo Pharmaceuticals Inc, Boehringer Ingelheim International GmbH, and Corium, LLC.

What is the estimated transdermal medical patch market size in 2022?

The transdermal medical patch market is estimated to be valued at US$ 8,247.21 million in 2022.

What are transdermal medical patch?

The transdermal medical patch is a medicated patch that can deliver drugs through skin portals directly to the bloodstream at a predetermined rate. This is the most comfortable dosage form – it is non-invasive, avoids the gastrointestinal tract and bypasses first-pass metabolism, can have multiday therapy, and can be terminated at any time.

Which segment by type led the transdermal medical patch market?

The matrix segment held the largest share of the market in 2022. Also, the same segment is estimated to register the highest CAGR in the market during the forecast period.

What is the market CAGR value of the transdermal medical patch market during the forecast period?

The CAGR value of the transdermal medical patch market during the forecasted period of 2023-2028 is 4.0%.

What are the driving factors for the global transdermal medical patch market across the world?

The factors that are driving the growth of the transdermal medical patch market are the increasing aging population, increasing prevalence of chronic diseases and growing consumption of tobacco and increasing partnerships with foreign entities. These are some of the major factors contributing to the growth of the transdermal medical patch industry.

Which region is projected to be the fastest-growing region in the global transdermal medical patch market?

The Asia Pacific is expected to be the fastest-growing region in the transdermal medical patch market over the forecast period due to the increasing prevalence of chronic diseases and the growing research on cancer and gene mutations, increasing disease modeling, and developments by market players offering transdermal medical patch.

What are the growth estimates for the transdermal medical patch market till 2028?

The transdermal medical patch market is expected to be valued at US$ 10,799.74 million in 2028.

The List of Companies - Transdermal Medical Patch Market

  1. Hisamitsu Pharmaceutical Co Inc
  2. Medline Industries LP
  3. Johnson & Johnson
  4. Novartis AG
  5. Teva Pharmaceutical Industries Ltd
  6. UCB SA
  7. Viatris Inc
  8. Endo Pharmaceuticals Inc
  9. Boehringer Ingelheim International GmbH
  10. Corium, LLC

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports